Incidence and risk of fatigue in cancer patients treated with MET inhibitors: A systematic review and meta-analysis

BACKGROUND: The N-methyl-N′-nitroso-guanidine human osteosarcoma transforming gene (MET) inhibitors show a surprising survival benefit in the treatment of numerous tumors especially in MET-high tumor. Besides their impressive efficacy, fatigue reduced by MET inhibitors is still the safety issue duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Hongxuan, Zhu, Yutian, Liu, Yihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709275/
https://www.ncbi.nlm.nih.gov/pubmed/31145273
http://dx.doi.org/10.1097/MD.0000000000015522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709275/
https://www.ncbi.nlm.nih.gov/pubmed/31145273
http://dx.doi.org/10.1097/MD.0000000000015522

Ejemplares similares